Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay

Clinical and Applied Thrombosis/Hemostasis

Volumn 12, Issue 3, 2006, Pages 296-304

  Casonato, A ^a,b   Fabris, F ^a   Pontara, E ^a   Cattini, M G ^a   Zocca, N ^a   Gallinaro, L ^a   Girolami, A ^a   Pagnan, A ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

von Willebrand factor; VWF multimers; VWF cp; VWF:CB

Indexed keywords

COLLAGEN; DIPYRIDAMOLE; IMMUNOGLOBULIN; POLYMER; RISTOCETIN; STEROID; TICLOPIDINE; VINCRISTINE; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BINDING ASSAY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HUMAN; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; SYMPTOM; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT RESPONSE;

ACUTE DISEASE; ADULT; COLLAGEN TYPE III; DIAGNOSTIC TECHNIQUES AND PROCEDURES; DIMERIZATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROTEIN BINDING; PURPURA, THROMBOTIC THROMBOCYTOPENIC; VON WILLEBRAND FACTOR;

EID: 33748745113     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029606291385     Document Type: Article

References (32)

1. Moschowitz E. Acute febrile pheocromic anemia with hyaline thrombosis of terminal arterioles and capillaries: An undescribed disease. Arch Intern Med 1925;36:89.
2. Upshaw JD. Congenital deficiency of a factor in normal plasma that reverses microangiopathic hemolysis and thrombocytopenia. N Engl J Med 1978;298:1350.
3. Ruggenenti P, Remuzzi G. The pathophysiology and management of thrombotic thrombocytopenic purpura. Eur J Haematol 1996;56:191.
4. Moake JL, Rudy CK, Troll JH, et al. Unsually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 1982;307:1432.
5. Moake JL, Byrnes JJ, Troll JH, et al. Abnormal VIII:von Willebrand factor patterns in the plasma of patients with the hemolytic-uremic syndrome. Blood 1984;64:592.
6. Ruggeri ZM, Zimmerman TS. The complex multimeric composition of factor VIII/von Willebrand factor. Blood 1981;57:1140.
7. Gralnick HR, Williams SB, Morisato DK. Effect of multimeric structure of the factor VIII/von Willebrand factor protein binding to platelets. Blood 1981;58:387.
8. Sporn LA, Marder VJ, Wagner DD. Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell 1986;46:185.
9. Furlan M, Robles R, Lammle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 1996;87:4223.
10. Tsai H-M. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 1986;87:4235.
11. Furlan M, Robles R, Solenthaler M, et al. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 1997-89:3097.
12. Gerritsen HE, Turecek PL, Schwarz HP, et al. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: A tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Thromb Haemost 1999;82:1386.
13. Aronson DL, Krizek DM, Rick ME. A rapid assay for the vWf protease. Thromb Haemost 2001;85:184.
14. Casonato A, Sartori MT, Pontara E, et al. Impaired release of tissue plasminogen activator (t-PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content. Blood Coagul Fibrinolysis 1992;3:149.
15. Casonato A, Fabris F, Vicariotto M, Girolami A. The evaluation of factor VIII antigen by means of a simple slide test. Am J Clin Pathol 1985;84:107.
16. Casonato A, Pontara E, Bertomoro A, et al. Abnormal collagen binding activity of 2A von Willebrand factor: Evidence that the defect depends only on the lack of large multimers. J Lab Clin Med 1997;129:251.
17. Ruggeri ZM, Zimmerman TS. Variant von Willebrand's disease: Characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets. J Clin Invest 1980;65:1318.
18. Wagner DD, Marder VJ. Biosynthesis of von Willebrand protein by human endothelial cells: Processing steps and their intracellular localization. J Cell Biol 1984;99:2123.
19. Casonato A, Pontara E, Bertomoro A, et al. Which assay is the most suitable to investigate von Willebrand factor functional activity? Thromb Haemost 1999;81:994.
20. Chow TW, Turner NA, Chintagumpala M, et al. Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura. Am J Haematol 1998;57:293.
21. Dent JA, Galbusera M, Ruggeri ZM. Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit. J Clin Invest 1991;88:774.
22. Fujikawa K, Suzuki H, McMullen B, Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 2001;98:1662.
23. Gerritsen HE, Robles R, Lammle B, Furlan M. Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood 2001;98:1654.
24. Caterson B, Flannery CR, Hughes CE, Little CB. Mechanisms involved in cartilage proteoglycan catabolism. Matrix Biol 2000;19:333.
25. Furlan M, Robles R, Solenthaler M, Lammle B. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood 1998;91:2839.
26. Tsai H-M, Lian EC-Y. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998;339:1585.
27. McFarlane DE, Stibbe J, Kibby EP, et al. A method for assaying von Willebrand factor (ristocetin co-factor). Thromb Diath Haemor 1975;34:306.
28. Ruggeri ZM, Zimmerman TS. Von Willebrand factor and von Willebrand disease. Blood 1987;70:895.
29. Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994;71:520.
30. Brown JE, Bosak JO. An ELISA test for the binding of von Willebrand antigen to collagen. Thromb Res 1986;43:303.
31. Casonato A, Pontara E, Bertomoro A, et al. Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: An alternative to ristocetin cofactor activity? Br J Haematol 1999;112:578.
32. Favaloro EJ. Von Willebrand factor collagen-binding (activity) assay in the diagnosis of von Willebrand disease: A 15-year journey. Semin Thromb Haemost 2000:191.